UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges Review article
2024
Authors:  Li, Chang Yun;  Wang, Wanhe;  Leung, Chung Hang;  Yang, Guan Jun;  Chen, Jiong
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:27.7/31.3 | Submit date:2024/06/05
Breast Cancer  Histone Demethylation  Kdm5  Kdm5 Inhibitors  Therapeutic Target  
Atomically precise vacancy-assembled quantum antidots Journal article
Fang, Hanyan, Mahalingam, Harshitra, Li, Xinzhe, Han, Xu, Qiu, Zhizhan, Han, Yixuan, Noori, Keian, Dulal, Dikshant, Chen, Hongfei, Lyu, Pin, Yang, Tianhao, Li, Jing, Su, Chenliang, Chen, Wei, Cai, Yongqing, Neto, A. H.Castro, Novoselov, Kostya S., Rodin, Aleksandr, Lu, Jiong. Atomically precise vacancy-assembled quantum antidots[J]. Nature Nanotechnology, 2023, 18(12), 1401-1408.
Authors:  Fang, Hanyan;  Mahalingam, Harshitra;  Li, Xinzhe;  Han, Xu;  Qiu, Zhizhan; et al.
Favorite | TC[WOS]:17 TC[Scopus]:17  IF:38.1/39.6 | Submit date:2024/01/02
Hot-electron Generation  Logic Gate  Semiconductor  Graphene  States  
Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease Review article
2022
Authors:  Zhang, Zhan;  Dalan, Rinkoo;  Hu, Zhenyu;  Wang, Jiong Wei;  Chew, Nicholas W.S.; et al.
Favorite | TC[WOS]:77 TC[Scopus]:82  IF:27.4/30.2 | Submit date:2022/08/05
Cardiovascular Disease  Diabetes  Hypercholesterolemia  Hypertension  Ischemia Heart Disease  Nanomedicine  Reactive Oxygen Species  
Pharmacological inhibition of KDM5A for cancer treatment Journal article
Yang, Guan Jun, Wu, Jia, Miao, Liang, Zhu, Ming Hui, Zhou, Qian Jin, Lu, Xin Jiang, Lu, Jian Fei, Leung, Chung Hang, Ma, Dik Lung, Chen, Jiong. Pharmacological inhibition of KDM5A for cancer treatment[J]. European Journal of Medicinal Chemistry, 2021, 226, 113855.
Authors:  Yang, Guan Jun;  Wu, Jia;  Miao, Liang;  Zhu, Ming Hui;  Zhou, Qian Jin; et al.
Favorite | TC[WOS]:26 TC[Scopus]:28  IF:6.0/6.1 | Submit date:2021/12/08
Cancer Therapy  Drug Resistance  Histone Methylation  Lysine-specific Demethylase 5a  Screening Methods  
A review on the emerging roles of pyruvate kinase M2 in anti-leukemia therapy Review article
2021
Authors:  Yang, Guan Jun;  Wu, Jia;  Leung, Chung Hang;  Ma, Dik Lung;  Chen, Jiong
Favorite | TC[WOS]:16 TC[Scopus]:16  IF:7.7/7.7 | Submit date:2022/01/14
Leukemia  Modulators  Pyruvate Kinase M2  
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer Journal article
Ping Chen, Xu Zhang, Renbo Ding, Linglin Yang, Xueying Lyu, Jianming Zeng, Josh Haipeng Lei, Lijian Wang, Jiong Bi, Nan Shao, Ditian Shu, Bin Wu, Jingbo Wu, Zhihui Yang, Haiyan Wang, Biqiong Wang, Kang Xiong, Yun Lu, Shaozhi Fu, Tak Kan Choi, Ng Wai Lon, Aiping Zhang, Dongyang Tang, Yingyao Quan, Ya Meng, Kai Miao, Heng Sun, Ming Zhao, Jiaolin Bao, Lei Zhang, Xiaoling Xu, Yanxia Shi, Ying Lin, Chuxia Deng. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer[J]. Advanced Science, 2021, 8(22), 2101176.
Authors:  Ping Chen;  Xu Zhang;  Renbo Ding;  Linglin Yang;  Xueying Lyu; et al.
Favorite | TC[WOS]:75 TC[Scopus]:75  IF:14.3/16.3 | Submit date:2021/11/30
Advanced Breast Cancer  Drug Screening  Patient-derived Organoids  Personalized Therapy  
The emerging role of KDM5A in human cancer Review article
2021
Authors:  Yang,Guan Jun;  Zhu,Ming Hui;  Lu,Xin Jiang;  Liu,Yan Jun;  Lu,Jian Fei; et al.
Favorite | TC[WOS]:62 TC[Scopus]:67  IF:29.5/26.9 | Submit date:2021/03/01
Cancer  Drug Resistance  Histone Methylation  Jumonji c Domain  Kdm5a  Targeted Therapy